Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cholangiocarcinoma × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18 Neoplasms 5 Neoplasm Metastasis 2 Urachal cancer 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Cancer Metastatic 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Carcinoma, Hepatocellular 1 Borderline Resectable Pancreatic Cancer 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 52 Cisplatin 29 Oxaliplatin 24 Fluorouracil 19 lenvatinib 18 durvalumab 18 Capecitabine 16 Leucovorin 13 pembrolizumab 9 apatinib 9 tislelizumab 7 sintilimab 6 pemigatinib 6 Radiotherapy 6 Panitumumab 6 Floxuridine 6 Albumin-Bound Paclitaxel 6 tremelimumab 5 olaparib 5 Taxes 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Folfox protocol 5 Drug Therapy 5 Bevacizumab 5 camrelizumab 4 Nivolumab 4 Irinotecan 4 Carboplatin 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02456714 2020-03-10

4CC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡